Inclusive of all taxes
Ceftazidime Pentahydrate for Injection 125 mg is a potent third-generation cephalosporin antibiotic formulated as a sterile dry powder for injection. Specifically designed to combat a broad spectrum of Gram-negative bacterial infections, it exhibits excellent efficacy against challenging pathogens such as Pseudomonas aeruginosa. Upon reconstitution, this injectable antibiotic is administered via intramuscular or intravenous routes, making it suitable for severe infections requiring rapid bioavailability. Ceftazidime functions by targeting and inhibiting bacterial cell wall synthesis, causing bacterial cell lysis and ultimately eradicating the infection. This targeted mechanism makes it an essential antibiotic in hospital settings for treating complicated urinary tract infections, lower respiratory tract infections, skin and soft tissue infections, and septicemia where Gram-negative bacteria are implicated. Its pentahydrate salt form ensures stability and potency during storage and handling, optimizing clinical efficacy. Ceftazidime Pentahydrate 125 mg is an ideal therapeutic choice for healthcare providers seeking reliable, injectable antibiotic options against multidrug-resistant Gram-negative bacterial infections.
Key Features
| Features | Description |
|---|---|
| Form | Sterile dry powder for injection |
| Strength | 125 mg of Ceftazidime Pentahydrate per vial |
| Route of Administration | Intravenous (IV) or Intramuscular (IM) injection |
| Antibacterial Spectrum | Effective against Gram-negative bacteria including Pseudomonas aeruginosa |
| Mechanism of Action | Inhibits bacterial cell wall synthesis causing bacterial lysis |
| Generation | Third-generation cephalosporin |
| Stability | Pentahydrate salt form enhances stability and potency |
| Indications | Treatment of serious Gram-negative infections such as UTIs, respiratory infections, septicemia |
| Packaging | Vial containing dry powder for reconstitution |
| Attributes | Description |
|---|---|
| Active Ingredient | Ceftazidime Pentahydrate |
| Dosage Strength | 125 mg per vial |
| Dosage Form | Injectable dry powder |
| Route | Intramuscular and Intravenous injection |
| Storage Conditions | Store below 25°C; protect from moisture and light |
| Reconstitution Solvent | Sterile water or suitable diluent as per prescribing information |
| Shelf Life | Typically 2 years from manufacture, subject to packaging |
| Pharmacological Class | Third-generation cephalosporin antibiotic |
| Packaging Type | Single-dose sterile vial |
| Bacterial Coverage | Broad spectrum Gram-negative including Pseudomonas aeruginosa |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Ceftazidime Pentahydrate 125 mg Injection is administered either by intravenous (IV) or intramuscular (IM) injection, depending on clinical requirements and severity of infection.
Yes, Ceftazidime Pentahydrate is specifically effective against Gram-negative bacteria, including Pseudomonas aeruginosa, making it suitable for treating infections caused by this pathogen.
The pentahydrate form enhances the chemical stability and shelf life of the drug, ensuring potency is maintained during storage and transport until reconstitution and use.
While generally used in hospital settings, intramuscular administration can facilitate outpatient treatment for certain infections, contingent on medical supervision and patient condition.
The injectable powder should be stored below 25°C, in a dry place protected from moisture and direct light to maintain drug efficacy.
Ceftazidime Pentahydrate for Injection 125 mg is a third-generation cephalosporin antibiotic, known for its strong activity against Gram-negative bacteria, including Pseudomonas aeruginosa.
Key Features:
Form: Dry powder for injection.
Strength: 125 mg of Ceftazidime Pentahydrate.
Route of Administration: Intravenous (IV) or intramuscular (IM).
Mechanism of Action: Ceftazidime works by inhibiting bacterial cell wall synthesis, leading to the lysis and death of the bacterial cell.
Inclusive of all taxes
You Save: 0
